INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 147 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $56,000 | +19.1% | 7,766 | 0.0% | 0.02% | +13.6% |
| Q1 2018 | $47,000 | -37.3% | 7,766 | 0.0% | 0.02% | -33.3% |
| Q4 2017 | $75,000 | -11.8% | 7,766 | -18.4% | 0.03% | -21.4% |
| Q3 2017 | $85,000 | -41.8% | 9,516 | -17.4% | 0.04% | -44.0% |
| Q2 2017 | $146,000 | +0.7% | 11,516 | -16.3% | 0.08% | -1.3% |
| Q1 2017 | $145,000 | +14.2% | 13,766 | 0.0% | 0.08% | +13.4% |
| Q4 2016 | $127,000 | +202.4% | 13,766 | +288.3% | 0.07% | +191.3% |
| Q3 2016 | $42,000 | -8.7% | 3,545 | 0.0% | 0.02% | -11.5% |
| Q2 2016 | $46,000 | -17.9% | 3,545 | +0.4% | 0.03% | -16.1% |
| Q1 2016 | $56,000 | -44.0% | 3,530 | +0.9% | 0.03% | -44.6% |
| Q4 2015 | $100,000 | 0.0% | 3,500 | 0.0% | 0.06% | -6.7% |
| Q3 2015 | $100,000 | -20.6% | 3,500 | 0.0% | 0.06% | -16.7% |
| Q2 2015 | $126,000 | +23.5% | 3,500 | +100.0% | 0.07% | +12.5% |
| Q1 2015 | $102,000 | +500.0% | 1,750 | +322.7% | 0.06% | +481.8% |
| Q4 2014 | $17,000 | – | 414 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,257,094 | $92,697,000 | 13.04% |
| JW Asset Management, LLC | 388,346 | $11,052,000 | 4.00% |
| Anson Funds Management LP | 400,200 | $11,390,000 | 3.31% |
| Orbimed Advisors | 4,081,800 | $116,168,000 | 1.17% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,718,487 | $48,908,000 | 1.05% |
| Bellevue Asset Management AG | 210,000 | $5,977,000 | 0.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 788,534 | $22,441,000 | 0.93% |
| Rock Springs Capital Management LP | 308,000 | $8,766,000 | 0.71% |
| JUNCTURE WEALTH STRATEGIES, LLC | 18,502 | $527,000 | 0.43% |
| B. Riley Wealth Management, Inc. | 8,600 | $244,000 | 0.35% |